|
Table 2: Cardiac lesions prevalence in echocardiogram and abnormalities detection by standard non-echocardiographic pre-participation screening. |
||
|
Type of lesion |
Prevalence N (% within lesions; % overall) |
Abnormal standard PPS N (% within type of lesion) |
|
Atrial septal aneurysm |
5 (13.9; 0.25) |
0 (0) |
|
Mitral valve prolapse |
5 (13.9; 0.25) |
1 (20) |
|
Atrial septal defect |
4 (11.1; 0.20) |
0 (0) |
|
Bicuspid aortic valve |
3 (8.4; 0.15) |
0 (0) |
|
Left ventricular hypertrophy |
3 (8.4; 0.15) |
0 (0) |
|
Ascending aortic dilation |
2 (5.6; 0.10) |
0 (0) |
|
Dilated cardiomyopathy |
2 (5.6; 0.10) |
1 (50) |
|
Left ventricle noncompaction |
2 (5.6; 0.10) |
0 (0) |
|
Ventricular septal defect |
2 (5.6; 0.10) |
1 (50) |
|
Coronary fistula (LCA-PT) |
1 (2.8; 0.05) |
0 (0) |
|
Corrected great arteries transposition |
1 (2.8; 0.05) |
1 (100) |
|
Dysplastic pulmonary valve stenosis |
1 (2.8; 0.05) |
1 (100) |
|
Hypertrophic cardiomyopathy |
1 (2.8; 0.05) |
1 (100) |
|
Patent ductus arteriosus |
1 (2.8; 0.05) |
0 (0) |
|
Persistent left superior vena cava |
1 (2.8; 0.05) |
0 (0) |
|
Right ventricle dilatation |
1 (2.8; 0.05) |
0 (0) |
|
Sub-aortic membrane |
1 (2.8; 0.05) |
0 (0) |
|
LCA = left coronary artery; PPS = preparticipation screening; PT = pulmonary trunk. |
||